AMERICAN SHARED HOSPITAL SERVICES Equity Method Investment, Realized Gain (Loss) on Disposal
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Equity Method Investment, Realized Gain (Loss) on Disposal of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-04-03.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal · last filed 2020-04-03
- AMERICAN SHARED HOSPITAL SERVICES equity method investment, realized gain (loss) on disposal for the quarter ending 2018-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES equity method investment, realized gain (loss) on disposal for the quarter ending 2018-09-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES equity method investment, realized gain (loss) on disposal for the quarter ending 2018-06-30 was $22.00K.
- AMERICAN SHARED HOSPITAL SERVICES equity method investment, realized gain (loss) on disposal for the quarter ending 2017-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES equity method investment, realized gain (loss) on disposal for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- AMERICAN SHARED HOSPITAL SERVICES equity method investment, realized gain (loss) on disposal for fiscal 2018 was $22.00K.
- AMERICAN SHARED HOSPITAL SERVICES equity method investment, realized gain (loss) on disposal for fiscal 2017 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES equity method investment, realized gain (loss) on disposal for fiscal 2016 was $0.00.
| Period end | Equity Method Investment, Realized Gain (Loss) on Disposal 3 month | Equity Method Investment, Realized Gain (Loss) on Disposal 6 month | Equity Method Investment, Realized Gain (Loss) on Disposal 9 month | Equity Method Investment, Realized Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-04-03 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $0.00 derived: sum of 2 quarters · filed 2020-04-03 | $22.00K derived: sum of 3 quarters · filed 2020-04-03 | $22.00K 10-K · filed 2020-04-03 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | $22.00K derived: sum of 2 quarters · filed 2018-11-09 | $22.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $22.00K 10-Q · filed 2018-08-09 | $22.00K 10-Q · filed 2018-08-09 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $0.00 derived: sum of 2 quarters · filed 2020-04-03 | $0.00 derived: sum of 3 quarters · filed 2020-04-03 | $0.00 10-K · filed 2020-04-03 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |